• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Treatment Optimization Challenges Associated With Heart Failure

Opinion
Video

Barriers to optimal heart failure treatment are broken down by the expert panelists.

This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright Jr, MD; Nancy Albert, PhD, CCNS, CCRN, CHFN, NE-BC, FAHA, FCCM, FHFSA, FAAN; Nihar Desai, MD, MPH; and Kelly Marie Axsom, MD. Despite remarkable advances, challenges remain in heart failure care. Albert identifies patient barriers such as transportation, scheduling, and medication adherence. However, the biggest issue is optimizing guideline-directed medical therapy because many providers do not maximize therapies. Desai notes that disparities in accessing new technologies could worsen without efforts to reach all patients equally. He advocates redefining the care team and delivery models. Axsom recommends managing patients remotely using home devices and data customized by insights into individuals’ lives. Wright cites overcoming outdated practices and misinformation as gaps, emphasizing education about current evidence. With more advanced practice providers, ongoing learning is essential. In summary, major needs include closing evidence-practice gaps, eliminating disparities, supporting patients holistically, and continuously updating providers on the evolving landscape.

Video synopsis is AI-generated and reviewed by AJMC editorial staff.

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Stephanie L. Graff, MD, an expert on breast cancer
B. Joy Snider, MD, PhD, and Maria Lopes, MD, MS
A panel of 5 experts on Alzheimer disease
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Chris Pagnani, MD, PC
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
Screenshot of Stephen Freedland, MD, during a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.